Vertex Pharmaceuticals Inc / Ma

Calamos Advisors LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

43,969

Value ($000)

19,934

Weight

0.1%

2013 Q4 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	19,934	0.1%	43,969	12/31/2025
2025 Q3	10/20/2025	17,919	0.1%	45,753	9/30/2025
2025 Q2	8/8/2025	20,369	0.1%	45,753	6/30/2025
2025 Q1	4/29/2025	22,182	0.1%	45,753	3/31/2025
2024 Q4	1/24/2025	18,220	0.1%	45,244	12/31/2024
2024 Q3	11/7/2024	21,042	0.1%	45,244	9/30/2024
2024 Q2	7/25/2024	21,764	0.1%	46,433	6/30/2024
2024 Q1	5/8/2024	20,116	0.1%	48,124	3/31/2024
2023 Q4	1/31/2024	28,145	0.1%	69,172	12/31/2023
2023 Q3	10/26/2023	24,375	0.1%	70,095	9/30/2023
2023 Q2	7/28/2023	24,667	0.1%	70,095	6/30/2023
2023 Q1	5/4/2023	25,701	0.1%	81,572	3/31/2023
2022 Q4	1/26/2023	26,498	0.1%	91,757	12/31/2022
2022 Q3	10/24/2022	31,249	0.1%	107,928	9/30/2022
2022 Q2	8/1/2022	30,403	0.1%	107,891	6/30/2022
2022 Q1	5/3/2022	27,398	0.1%	104,987	3/31/2022
2021 Q4	2/1/2022	20,017	0.1%	91,150	12/31/2021
2021 Q3	10/26/2021	20,126	0.1%	110,957	9/30/2021
2021 Q2	7/22/2021	25,809	0.1%	128,003	6/30/2021
2021 Q1	4/12/2021	42,821	0.3%	199,269	3/31/2021
2020 Q4	1/27/2021	33,579	0.2%	142,079	12/31/2020
2020 Q3	10/26/2020	39,772	0.3%	146,155	9/30/2020
2020 Q2	7/27/2020	49,917	0.4%	171,944	6/30/2020
2020 Q1	4/28/2020	27,282	0.2%	114,656	3/31/2020
2019 Q4	1/15/2020	9,136	0.1%	41,725	12/31/2019
2013 Q4	2/14/2014	3,205	0.0%	43,138	12/31/2013